1. Home
  2. STE vs TEVA Comparison

STE vs TEVA Comparison

Compare STE & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STE
  • TEVA
  • Stock Information
  • Founded
  • STE 1985
  • TEVA 1901
  • Country
  • STE United States
  • TEVA Israel
  • Employees
  • STE N/A
  • TEVA N/A
  • Industry
  • STE Industrial Specialties
  • TEVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • STE Health Care
  • TEVA Health Care
  • Exchange
  • STE Nasdaq
  • TEVA Nasdaq
  • Market Cap
  • STE 25.9B
  • TEVA 21.2B
  • IPO Year
  • STE 1992
  • TEVA N/A
  • Fundamental
  • Price
  • STE $257.27
  • TEVA $24.63
  • Analyst Decision
  • STE Buy
  • TEVA Strong Buy
  • Analyst Count
  • STE 9
  • TEVA 7
  • Target Price
  • STE $268.25
  • TEVA $25.86
  • AVG Volume (30 Days)
  • STE 776.8K
  • TEVA 13.4M
  • Earning Date
  • STE 11-05-2025
  • TEVA 11-05-2025
  • Dividend Yield
  • STE 0.98%
  • TEVA N/A
  • EPS Growth
  • STE 59.39
  • TEVA N/A
  • EPS
  • STE 6.97
  • TEVA 0.62
  • Revenue
  • STE $5,702,415,000.00
  • TEVA $16,776,000,000.00
  • Revenue This Year
  • STE $9.24
  • TEVA $4.11
  • Revenue Next Year
  • STE $6.30
  • TEVA $0.40
  • P/E Ratio
  • STE $36.86
  • TEVA $41.18
  • Revenue Growth
  • STE 7.08
  • TEVA 0.02
  • 52 Week Low
  • STE $200.98
  • TEVA $12.47
  • 52 Week High
  • STE $268.30
  • TEVA $26.38
  • Technical
  • Relative Strength Index (RSI)
  • STE 59.71
  • TEVA 68.64
  • Support Level
  • STE $256.71
  • TEVA $23.61
  • Resistance Level
  • STE $268.30
  • TEVA $26.38
  • Average True Range (ATR)
  • STE 6.00
  • TEVA 0.86
  • MACD
  • STE 1.47
  • TEVA 0.32
  • Stochastic Oscillator
  • STE 69.09
  • TEVA 73.27

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: